Kruidvat Allergieneusspray

Sodium cromoglicate, the active ingredient in Kruidvat Allergieneusspray, is a mast cell stabilizer presented as a nasal spray for nasal administration. It helps control symptoms of allergic rhinitis, including seasonal forms, by reducing the release of histamine and other inflammatory mediators. It is indicated for both perennial and seasonal allergic rhinitis, providing relief from nasal congestion, itching, and sneezing without systemic steroid exposure.

GNH USA supplies Kruidvat Allergieneusspray as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, ensuring quality and regulatory compliance across markets.

Sodium cromoglicate acts on mast cells to manage allergic nasal conditions.

Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhoea. Seasonal allergic rhinitis: provides symptom relief during pollen seasons. Perennial allergic rhinitis: controls year‑round nasal allergy symptoms.

Common Side Effects: - Nasal irritation or burning sensation. - Sneezing shortly after administration. - Dryness of the nasal mucosa. - Unpleasant taste or throat tickle. - Mild headache. - Transient epistaxis (nosebleed).

Serious or Rare Side Effects: - Throat swelling or angioedema. - Difficulty breathing or wheezing. - Severe or persistent nosebleeds. - Anaphylactic reaction. - Vision changes due to nasal pressure. - Persistent nasal ulceration.

Before using this nasal spray, consider the following precautions.

Pregnancy: consult a healthcare professional before use. Breastfeeding: discuss potential risks with a clinician. Hypersensitivity: avoid if known allergy to sodium cromoglicate or excipients. Nasal infection: do not use during active sinus or nasal infections. Children: follow prescriber guidance for pediatric use. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Sodium cromoglicate has a low potential for drug interactions, but monitor the following.

Major Interactions (Avoid): - Concurrent use with other mast cell stabilizers may increase local irritation.

Moderate Interactions (Monitor Closely): - Antihistamines may add to nasal dryness. - Intranasal corticosteroids may increase risk of mucosal irritation. - Decongestant nasal sprays can cause rebound congestion if combined. - Systemic corticosteroids may mask local irritation signs. - Beta‑2 agonist inhalers may reduce overall efficacy of allergy control.